Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide

Patrick Bogdanowicz, Marie-José Haure, Isabelle Ceruti, Sandrine Bessou-Touya, Nathalie Castex-Rizzi Department of Pharmacology, Pierre Fabre Dermo-Cosmétique, Toulouse, France Background: Glycation is an aging reaction of n...

Full description

Bibliographic Details
Main Authors: Bogdanowicz P, Haure MJ, Ceruti I, Bessou-Touya S, Castex-Rizzi N
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/results-from-in-vitro-and-ex-vivo-skin-aging-models-assessing-the-anti-peer-reviewed-article-CCID
_version_ 1828499121696145408
author Bogdanowicz P
Haure MJ
Ceruti I
Bessou-Touya S
Castex-Rizzi N
author_facet Bogdanowicz P
Haure MJ
Ceruti I
Bessou-Touya S
Castex-Rizzi N
author_sort Bogdanowicz P
collection DOAJ
description Patrick Bogdanowicz, Marie-José Haure, Isabelle Ceruti, Sandrine Bessou-Touya, Nathalie Castex-Rizzi Department of Pharmacology, Pierre Fabre Dermo-Cosmétique, Toulouse, France Background: Glycation is an aging reaction of naturally occurring sugars with dermal proteins. Type I collagen and elastin are most affected by glycation during intrinsic chronological aging. Aim: To study the in vitro and ex vivo assays in human skin cells and explants and the antiaging effects of glycylglycine oleamide (GGO). Materials and methods: The antiglycation effect of GGO was assessed in a noncellular in vitro study on collagen and, ex vivo, by immunohistochemical staining on human skin explants (elastin network glycation). The ability of GGO to contract fibroblasts was assessed in a functional assay, and its anti-elastase (MMP-12) activity was compared to that of oleic acid alone, glycylglycine (GG) alone, and oleic acid associated with GG. Results: In vitro, GGO reduced the glycation of type I collagen. Ex vivo, GGO restored the expression of fibrillin-1 inhibited by glycation. Furthermore, GGO induced a tissue retraction of almost 30%. Moreover, the MMP-12 activity was inhibited by up to 60%. Conclusion: Under the present in vitro and ex vivo conditions, GGO prevents glycation of the major structural proteins of the dermis, helping to reduce the risk of rigidification. By maintaining the elastic function of the skin, GGO may be a promising sparring partner for other topical antiaging agents. Keywords: extracellular matrix, glycylglycine oleamide, glycation, fibrillin-1, matrix metalloproteinase-12, skin aging
first_indexed 2024-12-11T13:18:24Z
format Article
id doaj.art-6c1a283214894757a7a7686e1076dafc
institution Directory Open Access Journal
issn 1178-7015
language English
last_indexed 2024-12-11T13:18:24Z
publishDate 2016-06-01
publisher Dove Medical Press
record_format Article
series Clinical, Cosmetic and Investigational Dermatology
spelling doaj.art-6c1a283214894757a7a7686e1076dafc2022-12-22T01:05:56ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152016-06-012016Issue 114315027554Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamideBogdanowicz PHaure MJCeruti IBessou-Touya SCastex-Rizzi NPatrick Bogdanowicz, Marie-José Haure, Isabelle Ceruti, Sandrine Bessou-Touya, Nathalie Castex-Rizzi Department of Pharmacology, Pierre Fabre Dermo-Cosmétique, Toulouse, France Background: Glycation is an aging reaction of naturally occurring sugars with dermal proteins. Type I collagen and elastin are most affected by glycation during intrinsic chronological aging. Aim: To study the in vitro and ex vivo assays in human skin cells and explants and the antiaging effects of glycylglycine oleamide (GGO). Materials and methods: The antiglycation effect of GGO was assessed in a noncellular in vitro study on collagen and, ex vivo, by immunohistochemical staining on human skin explants (elastin network glycation). The ability of GGO to contract fibroblasts was assessed in a functional assay, and its anti-elastase (MMP-12) activity was compared to that of oleic acid alone, glycylglycine (GG) alone, and oleic acid associated with GG. Results: In vitro, GGO reduced the glycation of type I collagen. Ex vivo, GGO restored the expression of fibrillin-1 inhibited by glycation. Furthermore, GGO induced a tissue retraction of almost 30%. Moreover, the MMP-12 activity was inhibited by up to 60%. Conclusion: Under the present in vitro and ex vivo conditions, GGO prevents glycation of the major structural proteins of the dermis, helping to reduce the risk of rigidification. By maintaining the elastic function of the skin, GGO may be a promising sparring partner for other topical antiaging agents. Keywords: extracellular matrix, glycylglycine oleamide, glycation, fibrillin-1, matrix metalloproteinase-12, skin aginghttps://www.dovepress.com/results-from-in-vitro-and-ex-vivo-skin-aging-models-assessing-the-anti-peer-reviewed-article-CCIDExtracellular matrixglycylglycine oleamideglycationfibrillin-1matrix metalloproteinase-12skin aging
spellingShingle Bogdanowicz P
Haure MJ
Ceruti I
Bessou-Touya S
Castex-Rizzi N
Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
Clinical, Cosmetic and Investigational Dermatology
Extracellular matrix
glycylglycine oleamide
glycation
fibrillin-1
matrix metalloproteinase-12
skin aging
title Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
title_full Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
title_fullStr Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
title_full_unstemmed Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
title_short Results from in vitro and ex vivo skin aging models assessing the antiglycation and anti-elastase MMP-12 potential of glycylglycine oleamide
title_sort results from in vitro and ex vivo skin aging models assessing the antiglycation and anti elastase mmp 12 potential of glycylglycine oleamide
topic Extracellular matrix
glycylglycine oleamide
glycation
fibrillin-1
matrix metalloproteinase-12
skin aging
url https://www.dovepress.com/results-from-in-vitro-and-ex-vivo-skin-aging-models-assessing-the-anti-peer-reviewed-article-CCID
work_keys_str_mv AT bogdanowiczp resultsfrominvitroandexvivoskinagingmodelsassessingtheantiglycationandantielastasemmp12potentialofglycylglycineoleamide
AT hauremj resultsfrominvitroandexvivoskinagingmodelsassessingtheantiglycationandantielastasemmp12potentialofglycylglycineoleamide
AT cerutii resultsfrominvitroandexvivoskinagingmodelsassessingtheantiglycationandantielastasemmp12potentialofglycylglycineoleamide
AT bessoutouyas resultsfrominvitroandexvivoskinagingmodelsassessingtheantiglycationandantielastasemmp12potentialofglycylglycineoleamide
AT castexrizzin resultsfrominvitroandexvivoskinagingmodelsassessingtheantiglycationandantielastasemmp12potentialofglycylglycineoleamide